Outcomes of immunosuppressant therapy with lower dose of antithymocyte globulin and cyclosporine in aplastic anemia.

@article{Malhotra2015OutcomesOI,
  title={Outcomes of immunosuppressant therapy with lower dose of antithymocyte globulin and cyclosporine in aplastic anemia.},
  author={Pankaj Malhotra and Vijay Bodh and Guru Subramanian Guru Murthy and Anup Kumar Datta and Neelam Varma and Subhash K. Varma},
  journal={Hematology},
  year={2015},
  volume={20 4},
  pages={239-44}
}
OBJECTIVE Immunosuppressant therapy (IST) with antithymocyte globulin (ATG) and cyclosporine is an established treatment option for patients with aplastic anemia (AA), who are not eligible for allogeneic stem cell transplantation. However, data on the dose of ATG and its efficacy from the developing countries is minimal. METHODS We performed a retrospective analysis of all AA patients (age >12 years), treated with equine ATG and cyclosporine from a single center in India. Patients who… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-2 of 2 extracted citations

Management of aplastic anaemia in pregnancy in a resource poor centre

The Pan African medical journal • 2016
View 5 Excerpts
Highly Influenced

Supportive Care and Newer Therapies in Aplastic Anaemia.

The Journal of the Association of Physicians of India • 2015

Similar Papers

Loading similar papers…